Designing Growth Strategies is in our DNA

Cell and Gene Therapy Market Size, Share & Industry Analysis, By Type (By Cell Therapy {By Therapy Type [CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer Cells, &Others], By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, & Others], By Indication [Oncology & Others]}, and By Gene Therapy {By Vector Type [Viral Vectors & Non-Viral Vectors], By Product Type [Zolgensma, Luxturna, Roctavian, & Others], and By Indication [Genetic Diseases, Ophthalmology, Hematology, & Others]}), By End User (Hospitals & Clinics, Specialty Clinics, & Others), and Regional Forecast, 2026-2034

Last Updated :July 9, 2026 | Format:PDF | Report ID: 114130

 

Speak to Analyst

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 220